• OPEN AN ACCOUNT
Indian Indices
Sensex
78,499.17 -455.59
( -0.58%)
Global Indices
Nasdaq
53,904.84 -465.28
(-0.86%)
Dow Jones
7,729.00 -15.55
(-0.20%)
Hang Seng
65,597.55 -85.71
(-0.13%)
Nikkei 225
10,873.25 -15.05
(-0.14%)
Forex
USD-INR
95.07 -0.16
(-0.17%)
EUR-INR
109.74 0.07
(0.06%)
GBP-INR
127.99 0.00
(0.00%)
JPY-INR
0.60 0.00
(-0.16%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.3622252
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
36.34
119157.18
EPS(TTM)
Face Value()
Div & Yield %
40.59
2
0.88
 

simplex papers ltd
Edelweiss Financial Services set to open Rs 350 cr public issue of NCDs
Feb 24,2026

Edelweiss Financial Services has approved the public issue of secured, redeemable, non-convertible debentures (NCDs) of face value of Rs 1000 each for an amount up to Rs 175 crore with a green shoe option of up to Rs 175 crore, cumulatively aggregating up to 35,00,000 NCDs for an amount aggregating up to Rs 350 crore. The issue opens on 02 March 2026 and closes on 16 March 2026.